UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Choosing a safe browser for crypto requires weighing security features and privacy controls. This intro provides a practical starting point.
20,779 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A rapid AI-driven capex cycle is widening the performance split between cap-weighted and equal-weight NASDAQ funds, u...
As investors eye the next earnings cycle, corvel (crvl) 2026 earnings take center stage. This article breaks down bus...
When a seasoned fund doubles down on a single stock, it sends a clear message. Frontier Capital Management recently e...
A disciplined, calendar-driven approach to investing is gaining ground as markets swing on tariff news and rate moves...
Analysts warn that a Cuba policy under Trump could mirror Venezuela’s approach, using sanctions and pressure to resha...
The NEOS Nasdaq-100 High Income ETF (QQQI) shows a 14% headline yield, but most of that payout is return of capital. ...
A new wave of government-backed AI infrastructure could unlock enormous opportunities for investors. This guide expla...
Nokia is quietly positioning itself as a top infrastructure play in AI networking, challenging Cisco's dominance with...
Orbital Industries closes a $50 million Series B to accelerate AI-powered materials discovery and move toward selling...
The Council of Multiple Listing Services asks federal antitrust regulators to recognize MLS collaborations as pro-com...
Investors cheered a decisive move higher as Okta unveiled AI-powered growth opportunities. The stock touched a new 52...